Lnc-SNHG5 Promoted Hepatocellular Carcinoma Progression Through the RPS3-NFκB Pathway

Jie Hao; Yu Liu; Fengli Guo; Guiming Fu; Junya Ning; Xianhui Ruan; Xiangqian Zheng; Ming Gao

doi:10.2147/IJGM.S442937

Lnc-SNHG5 Promoted Hepatocellular Carcinoma Progression Through the RPS3-NFκB Pathway

Int J Gen Med. 2023 Dec 1:16:5651-5664. doi: 10.2147/IJGM.S442937. eCollection 2023.

Authors

Jie Hao^#^{1

2

3}, Yu Liu^#¹, Fengli Guo^{1

4}, Guiming Fu^{1

5}, Junya Ning^{2

3}, Xianhui Ruan¹, Xiangqian Zheng¹, Ming Gao^{1

2

3}

Affiliations

¹ Department of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, People's Republic of China.
² Department of Breast and Thyroid Surgery, Tianjin Union Medical Center of Nankai University, Tianjin, People's Republic of China.
³ Tianjin Key Laboratory of General Surgery in Construction, Tianjin Union Medical Center Nankai University, Tianjin, People's Republic of China.
⁴ Department of Thyroid and Breast Surgery, Binzhou Medical University Hospital, Binzhou, People's Republic of China.
⁵ Thyroid-Otolaryngology Department, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center School of Medicine, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.

^# Contributed equally.

Abstract

Background: We planned to explore the underlying mechanism and clinical significance of lnc-SNHG5 and RPS3 in hepatocellular carcinoma in this current study.

Methods: The expression of Lnc-SNHG5 and RPS3 in HCC tissues and several cell lines were affirmed, respectively, using UALCAN, TIMER, TCGA and RT-qPCR assay. Cell proliferation ability was detected by colony formation assay and CCK8 assay. Cell apoptosis was monitored by flow cytometry assay. Next, the RPS3 expression levels and the related proteins in NFκB pathway were examined using Western blot analysis. The role of lnc-SNHG5 and RPS3 in vivo was identified by subcutaneous tumor bearing experiment.

Results: Lnc-SNHG5 was significantly increased in hepatocellular carcinoma tissues and in hepatocellular carcinoma cells. Further investigation showed that up-regulated lnc-SNHG5 promoted cell viability and cell proliferation ability of SMMC-7721 cells by regulating the cell apoptosis, while down-regulation of lnc-SNHG5 revealed opposite results in QGY-7703 cells. In terms of mechanism, we found that lnc-SNHG5 interacted with RPS3. Lnc-SNHG5 regulated the NFκB pathway through RPS3 in vitro and in vivo.

Conclusion: This study suggested that lnc-SNHG5 expression was signally up-regulated in hepatocellular carcinoma, and lnc-SNHG5 promoted the malignant phenotypes in vitro and in vivo via directly regulating RPS3-NFκB pathway. Lnc-SNHG5 might be a target for molecular targeted therapy, a potential and novel diagnostic marker for HCC patients.

Keywords: HCC; NFκB pathway; RPS3; SNHG5; long non-coding RNA.

Grants and funding

This work was partially supported by Tianjin Key Medical Discipline (Specialty) Construction Project [TJYXZDXK-058B]; Tianjin Health Research Project [NO. TJWJ2022XK024].